Top Markets
#1 COTI COTI +42.67%
#2 GALA GALA +33.41%
#3 Fabric Protocol Fabric Protocol +32.65%
#4 Magma Finance Magma Finance +29.45%
#5 Bitcoin Cash Bitcoin Cash +28.96%
#6 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +28.66%
#7 Tutorial Tutorial +27.51%
#8 Talus Network Talus Network +26.43%
#9 Zora Zora +24.71%
#10 Zcash Zcash +24.26%
Coin of the day
COTI COTI
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

DPH
Kedudukan dalam Saham #24500
Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the... Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the development, production, regulatory approval, marketing, and distribution of animal health products and associated goods for veterinarians. The company's activities are organized across three key segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. It supplies a broad range of veterinary treatments, encompassing endocrinology, dermatology, pain management and anesthetics, cardiovascular therapies, and critical care solutions for dogs and cats. For poultry, pigs, and cattle, offerings include water-soluble antibiotics, avian vaccines, and pain relief products. Equine health is addressed with products for lameness and pain. Furthermore, Dechra offers specialized pet nutrition designed to support therapeutic conditions in cats and dogs, such as allergies, obesity, and heart or kidney diseases. Its diversified operations also involve the distribution of veterinary pharmaceuticals and equipment, the provision of financial services, the promotion of pet food, and the creation, regulation, manufacturing, and commercialization of crop protection items. The company’s merchandise is primarily channeled to customers via extensive wholesaler and distributor networks. Founded in 1997 and headquartered in Northwich, UK, Dechra Pharmaceuticals PLC operates globally, with a significant presence in the United Kingdom, Germany, across Europe, the United States, and international markets.
Harga Saham
$52.60
Disegerakkan terakhir: 2024-01-15
Modal Pasaran
$59.92M
Perubahan (1 hari)
6.81%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Dechra Pharmaceuticals PLC (DPH)

Kategori

Healthcare
Nisbah P/E bagi Dechra Pharmaceuticals PLC (DPH)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Dechra Pharmaceuticals PLC, nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi Dechra Pharmaceuticals PLC dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 39.54 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 30.10 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 70.28 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 22.25 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 107.81 -
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.